These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 36830874)
1. Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin. Chiang KC; Gupta A; Sundd P; Krishnamurti L Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830874 [TBL] [Abstract][Full Text] [Related]
2. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state. Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019 [TBL] [Abstract][Full Text] [Related]
10. The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell disease. Jakubowski JA; Zhou C; Winters KJ; Lachno DR; Howard J; Payne CD; Mant T; Jurcevic S; Frelinger AL Platelets; 2015; 26(5):474-9. PubMed ID: 25140584 [TBL] [Abstract][Full Text] [Related]
11. Association between Vaso-occlusive Crises and Opioid Prescriptions among Patients with Sickle Cell Disease: A Retrospective Claims-based Study. Kang HA; Barner JC; Richards KM; Bhor M; Paulose J; Kutlar A J Health Econ Outcomes Res; 2020; 7(1):94-101. PubMed ID: 32685602 [TBL] [Abstract][Full Text] [Related]
12. Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based Study. Kang HA; Barner JC; Richards KM; Bhor M; Paulose J; Kutlar A J Health Econ Outcomes Res; 2020; 7(1):94-101. PubMed ID: 36873574 [No Abstract] [Full Text] [Related]
13. A novel inflammatory role for platelets in sickle cell disease. Davila J; Manwani D; Vasovic L; Avanzi M; Uehlinger J; Ireland K; Mitchell WB Platelets; 2015; 26(8):726-9. PubMed ID: 25548984 [TBL] [Abstract][Full Text] [Related]
14. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population). Elshazly SA; Heiba NM; Abdelmageed WM Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470 [TBL] [Abstract][Full Text] [Related]
15. ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease. Demagny J; Driss A; Stepanian A; Anguel N; Affo L; Roux D; Habibi A; Benghezal S; Capdenat S; Coppo P; Driss F; Veyradier A Res Pract Thromb Haemost; 2021 Jan; 5(1):197-203. PubMed ID: 33537544 [TBL] [Abstract][Full Text] [Related]
16. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease. Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790 [TBL] [Abstract][Full Text] [Related]
17. Risk of vaso-occlusive episodes in patients with sickle cell disease exposed to systemic corticosteroids: a comprehensive review. Ferreira de Matos C; Comont T; Castex MP; Lafaurie M; Walter O; Moulis G; Dion J; Cougoul P Expert Rev Hematol; 2022 Dec; 15(12):1045-1054. PubMed ID: 36412212 [TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospital. Martin OY; Darbari DS; Margulies S; Nickel RS; Leonard A; Speller-Brown B; Martin B; Barber JR; Webb J; Majumdar S; Sharron MP; Campbell AD Front Med (Lausanne); 2023; 10():987194. PubMed ID: 36873869 [TBL] [Abstract][Full Text] [Related]
19. COVID- 19 and sickle cell disease: autopsy findings of three deaths at the 37 Military Hospital, Accra, Ghana. Attoh SA; Sarkodie E; Fatchu R; Kuma AB; Asumanu E; McAddy M; Toppar A; Hobenu F; Agyeman-Bediako K; Edusei L; Akakpo PK Pan Afr Med J; 2022; 41():332. PubMed ID: 35865842 [TBL] [Abstract][Full Text] [Related]